Study of CM512 Injection in Subjects With Chronic Spontaneous Urticaria(CSU)

NCT07166211 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Spontaneous Urticaria (CSU)

Interventions

BIOLOGICAL: CM512 injection
DRUG: placebo

Sponsor

Keymed Biosciences Co.Ltd